Literature DB >> 1335468

Acute pyogenic Pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole.

J V Pether, W Jones, F B Greatorex, W Bunting.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335468     DOI: 10.1016/0163-4453(92)91799-h

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  5 in total

1.  Successful treatment of pulmonary pseudallescheriasis with itraconazole.

Authors:  M V Stolk-Engelaar; N J Cox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

2.  Amphotericin B responsive Scedosporium apiospermum infection in a patient with acute myeloid leukaemia.

Authors:  R Cunningham; D C Mitchell
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

Review 3.  Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.

Authors:  Joanna M Schaenman; Daniel B DiGiulio; Laurence F Mirels; Nancy M McClenny; Gerald J Berry; Annette W Fothergill; Michael G Rinaldi; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 4.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

5.  Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and terbinafine treatment: a case report and review of the literature.

Authors:  Eszter J Tóth; Géza R Nagy; Mónika Homa; Marianna Ábrók; Ildikó É Kiss; Gábor Nagy; Zsuzsanna Bata-Csörgő; Lajos Kemény; Edit Urbán; Csaba Vágvölgyi; Tamás Papp
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-04-14       Impact factor: 3.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.